Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 16, 2023
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinomaMichele Reni, Umberto Peretti, Marina Macchini, et al.
Cancer Treatment Reviews|August 21, 2021
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsMarina Macchini, Federico Centonze, Umberto Peretti, et al.
Cancer Treatment Reviews|February 20, 2022
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patientsMarina Macchini, Federico Centonze, Umberto Peretti, et al.
Current Drug Targets|March 31, 2012
Evidences and opinions for adjuvant therapy in pancreatic cancerMichele Reni
World Journal of Gastroenterology|October 19, 2010
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?Michele Reni
Methods and Protocols|April 27, 2026
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care SettingMaria Bernadette Cilona, Serena Nannipieri, Arianna Ferlito, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2020
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinomaMichele Reni, Umberto Peretti, Silvia Zanon, et al.
Expert Review of Anticancer Therapy|January 6, 2022
The impact of nutritional status on pancreatic cancer therapyGabriele Capurso, Nicolò Pecorelli, Alice Burini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 17, 2023
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapyMarina Macchini, Giulio Belfiori, Stefano Crippa, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Pageof 24